InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by PRYGOCKI MARK A SR, Director. Officer active across 1 companies, notably Clarus Therapeutics Holdings, Inc.. Cumulatively, 3 disclosures have been recorded. The latest transaction was filed on 7 June 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
01,922 shares0
Common Stock
SEC:0000899243-22-021761:0·
03,844 shares0
Common Stock
SEC:0000899243-21-048213·
03,844 shares0
Common Stock
SEC:0000899243-21-048213:0·
3 of 3 declarations
About PRYGOCKI MARK A SR
Mark A. Prygocki Sr is a Director at Clarus Therapeutics Holdings, Inc. In this role, he participates in the governance of the company, which specializes in developing medical treatments. Prygocki brings his expertise in corporate strategy, contributing to the direction and growth of Clarus Therapeutics.
